Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0000950170-24-056081

Options or other derivatives

  • Chief Executive Officer acquired 128,770 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kohli Prashant · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-06 Grant or award : show line 1 in the form Stock Options (Right to Buy) +128,770 128,770 D
Loading xslF345X05/ownership.xml…